TrialJapanese journal of ophthalmology2026

Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study.

Masaru Inatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.